Shares of Liberty Biopharma Inc (CVE:LTY – Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of C$2.00 and traded as low as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares traded.
Liberty Biopharma Price Performance
The company has a market capitalization of C$21.54 million and a price-to-earnings ratio of -12.66. The company has a fifty day simple moving average of C$2.00 and a two-hundred day simple moving average of C$2.00. The company has a debt-to-equity ratio of 8.19, a quick ratio of 0.12 and a current ratio of 0.12.
Liberty Biopharma Company Profile
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
- Five stocks we like better than Liberty Biopharma
- Where to Find Earnings Call Transcripts
- 3 large caps with red hot RSIs with upside
- How to Invest in Mining Stocks
- Johnson Controls International: Nothing but upside for investors
- Investing in Travel Stocks Benefits
- Unity Software’s resilient rebound post-earnings setback
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.